Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab.
Saved in:
| Title: | Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab. |
|---|---|
| Authors: | Giannicola, Rocco1 (AUTHOR), D'Arrigo, Graziella2 (AUTHOR), Botta, Cirino3 (AUTHOR), Agostino, Rita1 (AUTHOR), Del Medico, Pietro1 (AUTHOR), Falzea, Antonia Consuelo1 (AUTHOR), Barbieri, Vito3 (AUTHOR), Staropoli, Nicoletta3 (AUTHOR), Del Giudice, Teresa3 (AUTHOR), Pastina, Pierpaolo4 (AUTHOR), Nardone, Valerio4 (AUTHOR), Monoriti, Marika5 (AUTHOR), Calabrese, Graziella6 (AUTHOR), Tripepi, Giovanni2 (AUTHOR), Pirtoli, Luigi4,7 (AUTHOR), Tassone, Pierfrancesco3,8 (AUTHOR), Tagliaferri, Pierosandro3,8 (AUTHOR), Correale, Pierpaolo1 (AUTHOR) correalep@yahoo.it |
| Source: | Molecular & Clinical Oncology. Jul2019, Vol. 11 Issue 1, p81-90. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20499450 |
|---|---|
| DOI: | 10.3892/mco.2019.1859 |
